Ongoing research and development aim to enhance the treatments effectiveness and expand its capabilities
Novo Nordisk is facing a lawsuit from a woman who claims that the drug-maker inadequately warned about delayed gastric emptying from Mounjaro on the Prescribing Information, but failed to fully inform doctors and patients about the risk of stomach paralysis (gastroparesis), extreme nausea and vomiting, and other side effects
These may include nutritional counseling, exercise programs, behavioral support and FDA-approved medications like GLP-1 injections or the Wegovy pill
Alhadeff et al., GLP-1 and corticostriatal-limbic circuitry GLP-1 may decrease the rewarding effect of food and drugs of abuse by acting on the mesolimbic pathway (Dossat et al., 2011
Prioritize the chicken, the steak, the eggs
How GLP-1 supports metabolic health